4.29pm – 4.49pm GMT, 20 December 2024 ‐ 20 mins
Podium Lecture
CEO & Founder, Naitive
Will is a graduate of the MD/PhD programme at the University of Cambridge. He holds a PhD in Biochemistry, and practiced as a doctor in London, before leaving medicine to co-found Naitive Technologies.
Present
Chairman of ODEP (Orthopaedic Data Evaluation Panel) and the “Beyond Compliance advisory group”
Chaiman ISR (International Spinal Registries)
Member of the Implant Performance Committee NJR
Member of Network of Registries of Europe,
Member of the working group on dangers of Cobalt in TJR
Trustee for the Gwen Fish Trust.
Past
Consultant General Orthopaedic surgeon in Norwich 1977-2017
Secretary and President of the British Hip Society.
Member of the Steering and chair of the Implant performance NJR committees.
Trustee for ORUK
Author and co-author on numerous orthopaedic papers and chapters in books.
Present Research
The use of machine learning in areas of orthopaedics, particularly Hip Replacement.
Hobbies: Family and I run a small farm and a small woodland with my wife
James Naylor is a Senior Marketing Manager for Johnson & Johnson MedTech and works across digital technology and Hips. James has been in Orthopaedics as part of Sales or Marketing for more than 20 years starting as a sales rep and moving through to his current role as a Strategic Marketer for the Global Group. In his current role James is responsible for the management and delivery of digital projects within Hips and owns the future roadmaps for digital technology Globally for Hips. James’ role involves sourcing companies and products that fit the roadmaps and onboarding those companies as valued partners.
Stakeholder Engagement Manager, NIHR coordinating Centre
Helen joined the NIHR in 2016 to lead on stakeholder engagement activity with the charity and med tech communities and provide leadership and delivery for a number of high profile strategic and operational projects across NIHR.
Helen has led business/ governance changes at the science-policy interface with > 9 years research programmes commissioning experience. She developed applied research programmes from end to end to address pressing government and industry needs and has extensive experience working across government departments. Helen has developed the evidence supporting a number of national strategies and presented evidence-based findings at all organisational levels and internationally through the OECD.
Helen helps charities and med tech SMEs engage and develop fruitful collaborations with the NIHR and across the wider life sciences ecosystem. She is an innovation advisory board member to CW Innovation, the partnership between Chelsea and Westminster NHS Foundation Trust and the Trust’s hospital charity, CW+ and is a member of the West Midlands Health Tech Innovation Accelerator Grants Committee.